Clinical Trial Update: Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

View source ↗

Summary

A completed prospective study assessing insulin resistance and cardiovascular disease risk in men undergoing androgen deprivation therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Prostate Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | Status: COMPLETED